HRP20000479B1 - New pentasaccharides, their methods of production and pharmaceutical compositions containing the same - Google Patents

New pentasaccharides, their methods of production and pharmaceutical compositions containing the same

Info

Publication number
HRP20000479B1
HRP20000479B1 HR20000479A HRP20000479A HRP20000479B1 HR P20000479 B1 HRP20000479 B1 HR P20000479B1 HR 20000479 A HR20000479 A HR 20000479A HR P20000479 A HRP20000479 A HR P20000479A HR P20000479 B1 HRP20000479 B1 HR P20000479B1
Authority
HR
Croatia
Prior art keywords
production
methods
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
HR20000479A
Other languages
English (en)
Croatian (hr)
Inventor
Petitou Maurice
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of HRP20000479A2 publication Critical patent/HRP20000479A2/hr
Publication of HRP20000479B1 publication Critical patent/HRP20000479B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HR20000479A 1998-01-19 2000-07-19 New pentasaccharides, their methods of production and pharmaceutical compositions containing the same HRP20000479B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800514A FR2773801B1 (fr) 1998-01-19 1998-01-19 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
PCT/FR1999/000045 WO1999036428A1 (fr) 1998-01-19 1999-01-13 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
HRP20000479A2 HRP20000479A2 (en) 2001-02-28
HRP20000479B1 true HRP20000479B1 (en) 2006-04-30

Family

ID=9521913

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000479A HRP20000479B1 (en) 1998-01-19 2000-07-19 New pentasaccharides, their methods of production and pharmaceutical compositions containing the same

Country Status (39)

Country Link
US (1) US6670338B1 (ko)
EP (1) EP1049706B1 (ko)
JP (1) JP4695756B2 (ko)
KR (1) KR100533565B1 (ko)
CN (1) CN1172948C (ko)
AR (1) AR012779A1 (ko)
AT (1) ATE241637T1 (ko)
AU (1) AU744137B2 (ko)
BR (1) BR9907100B1 (ko)
CA (1) CA2318326C (ko)
CO (1) CO4970823A1 (ko)
CZ (1) CZ299817B6 (ko)
DE (1) DE69908298T2 (ko)
DK (1) DK1049706T3 (ko)
DZ (1) DZ2706A1 (ko)
EE (1) EE04194B1 (ko)
EG (1) EG23760A (ko)
ES (1) ES2200494T3 (ko)
FR (1) FR2773801B1 (ko)
GT (1) GT199900006A (ko)
HK (1) HK1029999A1 (ko)
HR (1) HRP20000479B1 (ko)
HU (1) HU228335B1 (ko)
IL (2) IL137240A0 (ko)
MY (1) MY125636A (ko)
NO (1) NO316894B1 (ko)
NZ (1) NZ505614A (ko)
PL (1) PL191098B1 (ko)
PT (1) PT1049706E (ko)
RU (1) RU2193040C2 (ko)
SA (1) SA99191114B1 (ko)
SI (1) SI1049706T1 (ko)
SK (1) SK284176B6 (ko)
TR (1) TR200002077T2 (ko)
TW (1) TW550267B (ko)
UA (1) UA61124C2 (ko)
UY (1) UY25357A1 (ko)
WO (1) WO1999036428A1 (ko)
ZA (1) ZA99357B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
CN100338084C (zh) * 2004-07-02 2007-09-19 北京大学 抑制异种器官移植免疫排斥反应的五糖抗原的合成方法
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
US20070191306A1 (en) * 2005-08-17 2007-08-16 Bristol-Myers Squibb Company FACTOR Xa INHIBITOR FORMULATION AND METHOD
EP1908768A1 (en) * 2006-10-05 2008-04-09 Endotis Pharma Anticoagulant compounds
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
EP2323605A4 (en) * 2008-09-10 2014-02-05 Syneron Medical Ltd TRANSDERMAL RELEASE OF OLIGOSACCHARIDES
WO2011014793A2 (en) 2009-07-31 2011-02-03 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
EP2721044B1 (en) * 2011-06-17 2015-11-18 Carbomimetics Synthetic pentasaccharides having short half-life and high activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
ATE190619T1 (de) * 1993-09-01 2000-04-15 Akzo Nobel Nv Biskonjugate, die zwei saccharide und einen spacer enthalten
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
FR2773801B1 (fr) 2000-05-12
HUP0102042A1 (hu) 2001-10-28
CZ20002636A3 (cs) 2000-11-15
AU1974699A (en) 1999-08-02
SK284176B6 (sk) 2004-10-05
TR200002077T2 (tr) 2000-12-21
US6670338B1 (en) 2003-12-30
IL137240A0 (en) 2001-07-24
FR2773801A1 (fr) 1999-07-23
DE69908298D1 (de) 2003-07-03
NZ505614A (en) 2003-02-28
TW550267B (en) 2003-09-01
NO20003661D0 (no) 2000-07-17
KR100533565B1 (ko) 2005-12-06
WO1999036428A1 (fr) 1999-07-22
HK1029999A1 (en) 2001-04-20
DK1049706T3 (da) 2003-09-29
ATE241637T1 (de) 2003-06-15
CO4970823A1 (es) 2000-11-07
JP2002509154A (ja) 2002-03-26
PL191098B1 (pl) 2006-03-31
AR012779A1 (es) 2000-11-08
SK10792000A3 (sk) 2001-01-18
EP1049706B1 (fr) 2003-05-28
RU2193040C2 (ru) 2002-11-20
HRP20000479A2 (en) 2001-02-28
EE200000421A1 (et) 2003-06-16
ZA99357B (en) 2000-07-19
GT199900006A (es) 2000-07-12
DE69908298T2 (de) 2004-04-01
UA61124C2 (en) 2003-11-17
EG23760A (en) 2007-08-08
HUP0102042A3 (en) 2003-07-28
CA2318326C (en) 2010-07-06
PL341874A1 (en) 2001-05-07
CZ299817B6 (cs) 2008-12-03
CN1172948C (zh) 2004-10-27
CN1293679A (zh) 2001-05-02
CA2318326A1 (en) 1999-07-22
ES2200494T3 (es) 2004-03-01
EE04194B1 (et) 2003-12-15
EP1049706A1 (fr) 2000-11-08
IL137240A (en) 2007-10-31
NO20003661L (no) 2000-09-19
JP4695756B2 (ja) 2011-06-08
MY125636A (en) 2006-08-30
HU228335B1 (en) 2013-03-28
UY25357A1 (es) 2000-12-29
AU744137B2 (en) 2002-02-14
EE200000421A (et) 2001-12-17
BR9907100B1 (pt) 2013-09-03
SI1049706T1 (en) 2003-12-31
PT1049706E (pt) 2003-09-30
SA99191114B1 (ar) 2006-10-11
BR9907100A (pt) 2000-10-24
DZ2706A1 (fr) 2003-09-01
NO316894B1 (no) 2004-06-14
KR20010034205A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
HRP20000479B1 (en) New pentasaccharides, their methods of production and pharmaceutical compositions containing the same
DE69933147D1 (de) Sustiuierte cyclische verbindungen, verfahren zu ihrer herstellung sowie sie enthaltende pharmazeutische zusammesetzungen
ES2071033T3 (es) Nuevos derivados de n-aril y n-heteroarilamida y urea como inhibidores de la acil coenzima a: colesterol acil transferasa.
ATE184294T1 (de) Poly-3-hydroxyalkanoate und verfahren zu ihrer herstellung
RS49531B (sr) Estrogen agonisti/antagonisti
RS49628B (sr) Medicinski aerosolni proizvodi
MX9203150A (es) Nuevos esteres de acidos tienilcarboxilicos de aminoalcoholes, sus productos de cuaternizacion y las composiciones farmaceuticas que los contienen.
HRP20020540B1 (en) New modulators of dopamine neurotransmission
ATE25974T1 (de) Acyl-substituierte derivate von 1,2,3,4tetrahydroisochinolin-3-carboxysaeuren, ihre salze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung.
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
CO4750662A1 (es) DERIVADOS DE BENZO (g) QUINOLINA
DE3675087D1 (de) Pyridoncarbonsauere-derivate und verfahren zu ihrer herstellung.
ZA9610418B (en) Phenylimidazolidines containing in particular a nitrooxy or carbonyloxy radical, preparation process and intermediates, use as medicaments, new uses and pharmaceutical compositions.
HUP0003826A2 (hu) Új triazolo [4,5-d] pirimidin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
TR200000850T2 (tr) Aerosol olmayan traş jeli bileşimleri.
DK0984934T3 (da) Hidtil ukendte oralt aktive jern(III)chelateringsmidler
WO2002007677A3 (en) Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
MA26418A1 (fr) Piperidones, procedes pour leur preparation et compositions pharmaceutiques les contenant
IE40603B1 (en) New hydroaromatic compounds
GB1285400A (en) Esters of substituted anthranilic acid
ES2143833T3 (es) Acidos y esteres de la diosmetina y composiciones farmaceuticas que los contienen.
YU75394A (sh) Anelirani dihidropiridini i njihova primena za pripremanje farmaceutskih preparata
FR2707089B1 (fr) Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ZA9710960B (en) Substituted tetrahydropyridine compounds, process for preparing them and pharmaceutical compositions containing them.
ATE42279T1 (de) Guanidinobenzoesaeureesterderivate, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: SANOFI-AVENTIS, FR

PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS, FR

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20161214

Year of fee payment: 19

PBON Lapse due to non-payment of renewal fee

Effective date: 20180131